Regenxbio (RGNX) Tops Q3 EPS by 10c

Regenxbio (NASDAQ: RGNX) reported Q3 EPS of ($1.20), $0.10 better than the analyst estimate of ($1.30). Revenue for the quarter came in at $29.7 million versus the consensus estimate of $24.63 million.

For earnings history and earnings-related data on Regenxbio (RGNX) click here.

You May Also Be Interested In

• BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
• ZKH Group Limited (ZKH) Reports Q2 EPS of $0.04
• Mizuho Reiterates Outperform Rating on Alibaba (BABA)